SecBot SecBot
Institutional Cluster

COLL

COLLEGIUM PHARMACEUTICAL, INC
BEARISH
Impact 4/10
Horizonweeks Processed7d 4h ago
Institutional cluster: 4 buyers, 6 sellers (mixed)
Actionable Insight ▼ Bearish

The 20:1 ratio of selling to buying, combined with a full exit by a top-5 holder (Assenagon) and no insider buying, signals institutional loss of conviction. Monitor next 10-Q for further position unwinds and any insider open-market purchases as a potential reversal signal.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$24.47
T+0 close · Nov 9, 2026 · via day close
Latest settled
+1.39%
T+1 · $24.81 · next T+5 in 4h
Vs SPY
+0.07%
α at T+1
Latest observation
+5.45%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $24.47entry
  2. T+1 · 6d ago +1.39%α +0.07% · $24.81
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Institutional activity in COLLEGIUM PHARMACEUTICAL during Q3 2026 was mixed: 4 small buyers added $1.1M in net new positions, while 6 sellers reduced holdings by $23.3M, including a full exit by Assenagon Asset Management ($11.2M) and a large trim by Royce & Associates ($7.1M). The selling cluster is 20x larger than buying, suggesting institutional de-risking after Q3 earnings showed declining EBITDA and pain portfolio revenue, despite an EPS beat.

Key Financial Metrics

Direction
distributing
Buy Value
$4.6M
Sell Value
$23.3M
Net Flow
-$22.2M

Institutional Positions

Net institutional flow: -$22.2M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Creative PlanningDOUBLED+145.9%$2.2M$721.0K
Squarepoint OpsADD+87.7%$2.0M$228.0K
Simplex TradingDOUBLED+288.9%$332.0K$191.0K

▼ Sellers (6)

InstitutionActionChangePrev ValueValue Δ
Assenagon Asset ManagementEXIT-100%$11.2M-$11.2M
Royce & AssociatesTRIM-32.3%$12.0M-$7.1M
BarclaysTRIM-65.6%$3.9M-$3.1M
CitigroupTRIM-36.2%$1.6M-$973.0K
Fifth Third BancorpNEAR_EXIT-76.5%$1.0M-$901.0K

Key Facts

  • 6 institutional sellers reduced positions by $23.3M in Q3 2026
  • 4 institutional buyers added $1.1M in net new positions
  • Assenagon Asset Management fully exited an $11.2M position (308.9K shares)
  • Royce & Associates trimmed $7.1M (107.3K shares), a 32.3% reduction
  • Barclays trimmed $3.1M (70.7K shares), a 65.6% reduction
  • Largest buyer Creative Planning doubled its position to $2.2M (+$721K)
  • No open-market insider buying corroborates the institutional cluster
  • Q3 2026 earnings showed 9% decline in adjusted EBITDA and 18% drop in pain portfolio revenue

Financial Impact

Net institutional selling of $22.2M ($23.3M sold vs $1.1M bought), representing approximately 2.7% of market cap

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been adjusted since quarter-end
  • Selling cluster may reflect sector rotation or tax-loss harvesting rather than company-specific concerns
  • Q3 EPS beat and reaffirmed guidance could attract new buyers, offsetting the selling signal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-COLL-2026-Q3

Track record

24 reports on COLL

Performance horizon

1 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 settles Nov 17
  2. Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 ▼ −1.39% −0.07% vs SPY
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 ▲ +1.39% +0.07% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Viewing Entry $24.47 to $24.81 ▼ −1.39% −0.07% vs SPY
  5. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  6. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 ▼ −3.78% −4.09% vs SPY
  7. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 ▼ −0.50% −0.03% vs SPY
  8. Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 ▼ −0.96% +0.82% vs SPY
  9. Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 ▼ −0.96% +0.82% vs SPY
  10. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 ▼ −2.30% −1.78% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026